Skip Navigation LinksHome > July 2013 - Volume 21 - Issue 4 > Use of Ceftaroline in the Management of Vertebral Osteomyeli...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e318276959f
Case Reports

Use of Ceftaroline in the Management of Vertebral Osteomyelitis: Case Report

Zainah, Hadeel MD; Hammoud, Marwa MD; Vazquez, Jose A. MD

Collapse Box

Abstract

Abstract: Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.

© 2013 by Lippincott Williams & Wilkins.

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.